)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
NBCC sold selling rights for 609 units in Amrapali's Aspire Leisure Valley and Centurion Park to AU Real Estate to raise funds for completing stalled housing projects
The NPPA has extended the knee implant price cap despite industry requests to remove or relax it, citing rising costs and innovation needs, as the regulator prioritises affordability for patients
A 7-member AIMED delegation explored regulatory alignment, market access and technology-sharing opportunities in the UK as India targets a sharp rise in medical device exports by 2030
The launch comes five months after YEIDA had warned the developer of cancelling its allotment for a 100-acre Greenbay Golf Village over failure to deposit outstanding dues at the time
This would unlock export potential of $6 billion for Indian pharma companies
Realty developer Anant Raj has signed an MoU with the Andhra Pradesh government to invest Rs 4,500 crore in a data and cloud services centre, a move expected to create nearly 16,000 jobs
Novo Nordisk will strengthen its oral semaglutide portfolio led by Rybelsus while cutting Wegovy injection prices by up to 37% to improve accessibility and expand its market in India
Despite this, the CDMO segment remained Akums' key growth driver, contributing Rs 804 crore, or 79 per cent of its total revenue
India sales grew 14% Y-o-Y to ₹2,766 crore in the September quarter, while international sales rose 29.5% to ₹1,189 crore, contributing 31.7% to overall revenue
Key micro-markets saw an increase in leasing activity, with e-commerce and 3PL players gaining momentum
India made strong gains in TB reduction, cutting incidence by 21% since 2015, but still accounted for 25% of global cases in 2024, according to the WHO's Global TB Report 2025
The Union Health Ministry held consultations to strengthen nursing education and governance, focusing on reforms, skill enhancement and equitable workforce distribution across India
The Centre has asked all states and UTs to open chest clinics under the National Programme on Climate Change and Human Health to tackle pollution-related illnesses during peak smog months
Buyer and investor interest in India's hill property markets has grown 8.2% YoY in Q3 2025, led by improved connectivity, lifestyle upgrades, and flexible work options, according to Magicbricks
Developers say adhering to Graded Response Action Plan Phase III is crucial but argue construction is not a major pollution source and blanket bans disrupt timelines and affect workers' livelihoods
Servier India has tied up with MedGenome and Reliance-backed Strand Life Sciences to offer low-cost IDH1 and IDH2 biomarker testing for rare cancers like AML and CCA across India
The company's revenue from operations rose to Rs 2,269.8 crore, a 13.4 per cent increase from Rs 2,001.9 crore in Q2FY25
The revenue department had contested a 2019 order of the Customs, Excise and Service Tax Appellate Tribunal (CESTAT), which had quashed a tax demand exceeding Rs 10 crore
Move comes in a bid to gain more space in India's anti-obesity market dominated by Mounjaro
2.4 mg injectable Poviztra to mark next phase of weight-loss rollout